You're not alone. We're here to help.

Eligible patients can save on SPIRIVA every month

savings-card

If you have commercial insurance, you may be eligible to pay as little as $0* a month for your SPIRIVA prescription. And, even if you don't qualify, SPIRIVA offers a low co-pay cost for many patients with commercial and Medicare insurance plans. Talk to your doctor about treating your COPD with SPIRIVA.
Start here to see if you qualify

Sign up to receive helpful emails

emails emails

Get ongoing communication via email about COPD and daily maintenance treatment with SPIRIVA to help you stay on track in your journey to better breathing. Register now

Stick with your treatment with RespiPoints™

This free, exclusive rewards program is a great way for people taking SPIRIVA RESPIMAT to get the most out of their COPD treatment.

Sign up today!

Restrictions apply, see amazon.com/gc-legal

  • Earn points daily for taking SPIRIVA RESPIMAT
  • Redeem your earned points for e-gift cards
  • Track your medication and know when it’s time to refill your prescription
  • Easily link your savings card to also earn points

Restrictions apply, see
amazon.com/gc-legal

*Eligible patients or patient guardians who are 18 years of age or older may pay as little as $0/month with a maximum savings up to $100/monthly prescription. Card valid for 12 consecutive months from activation date. Eligible patients may re-enroll for additional 12 consecutive-month periods by reactivating expired card, benefits not to exceed program expiration on 12/31/2019. If you live in Massachusetts, card expires on the earlier of July 1, 2019, or date AB-rated generic equivalent is available. One card per patient, not transferrable, and cannot be combined with any other offer. Program not health insurance. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Vet. Aff., Dept. of Def., or Tricare and where prohibited by law. Offer may change at any time, without notice.

IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT (tiotropium bromide) Inhalation Spray and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT and SPIRIVA HANDIHALER (continued)

Do not use SPIRIVA RESPIMAT or SPIRIVA HANDIHALER if you are allergic to tiotropium, ipratropium, atropine or similar drugs, or any ingredient in these medicines.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER are not rescue medicines and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause allergic reactions. Symptoms can include raised red patches on your skin (hives), itching, rash and/or swelling of the lips, tongue, or throat that may cause difficulty in breathing or swallowing. If you have any of these symptoms, stop taking the medicine and seek emergency medical care.

Before using SPIRIVA HANDIHALER, tell your doctor if you have a severe allergy to milk proteins.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause your breathing to suddenly get worse (bronchospasm). If this happens, use your rescue inhaler, stop taking SPIRIVA, and call your doctor right away or seek emergency medical care.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can increase the pressure in your eyes (acute narrow-angle glaucoma) which can cause the following symptoms: eye pain, blurred vision, seeing halos or colored images along with red eyes. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

Dizziness and blurred vision may occur with SPIRIVA RESPIMAT or SPIRIVA HANDIHALER. If you experience these symptoms, use caution when engaging in activities such as driving a car, or operating appliances or machinery.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause new or worsened urinary retention. Symptoms of blockage in your bladder and/or enlarged prostate may include difficulty passing urine and/or painful urination. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

The most common side effects reported with SPIRIVA RESPIMAT in patients with COPD include sore throat, cough, dry mouth, and sinus infection.

The most common side effects with SPIRIVA RESPIMAT in adult patients with asthma were sore throat, headache, bronchitis, and sinus infection. The side effect profile for adolescent and pediatric patients was comparable to that observed in adult patients with asthma.

The most common side effects reported with SPIRIVA HANDIHALER in patients with COPD include upper respiratory tract infection, dry mouth, sinus infection, sore throat, non-specific chest pain, urinary tract infection, indigestion, runny nose, constipation, increased heart rate, and blurred vision.

Do not swallow SPIRIVA capsules. The contents of the capsule should only be inhaled through your mouth using the HANDIHALER device.

Do not spray SPIRIVA RESPIMAT into your eyes, as this may cause blurring of vision and pupil dilation.

Tell your doctor about all your medical conditions including kidney problems, glaucoma, enlarged prostate, problems passing urine, or blockage in your bladder.

Tell your doctor all the medicines you take, including eye drops. Ask your doctor if you are taking any anticholinergic medicines because taking them together with SPIRIVA can increase side effects. Do not use SPIRIVA RESPIMAT and SPIRIVA HANDIHALER together.

INDICATIONS for SPIRIVA RESPIMAT (tiotropium bromide) and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

SPIRIVA RESPIMAT, 2.5 mcg, and SPIRIVA HANDIHALER are long-term, once-daily, prescription maintenance medicines used to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing your airways and keeping them open. COPD includes chronic bronchitis and emphysema. SPIRIVA RESPIMAT and SPIRIVA HANDIHALER also reduce the likelihood of flare-ups (COPD exacerbations).

SPIRIVA RESPIMAT, 1.25 mcg, is a long-term, once-daily, prescription maintenance treatment of asthma for people 6 years and older.

SPIRIVA is not a treatment for sudden symptoms of asthma or COPD.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information for SPIRIVA RESPIMAT, including Instructions for Use, and full Prescribing Information for SPIRIVA HANDIHALER, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION for STIOLTO RESPIMAT (continued)
IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT (tiotropium bromide) and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

Do not use SPIRIVA RESPIMAT or SPIRIVA HANDIHALER if you are allergic to tiotropium, ipratropium, atropine or similar drugs, or any ingredient in these medicines.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER are not rescue medicines and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause allergic reactions. Symptoms can include raised red patches on your skin (hives), itching, rash and/or swelling of the lips, tongue, or throat that may cause difficulty in breathing or swallowing. If you have any of these symptoms, stop taking the medicine and seek emergency medical care.